Fighting Lung Cancer with Conventional Therapies

Buch | Hardcover

405 Seiten

2015
Nova Science Publishers Inc (Verlag)
978-1-63483-275-5 (ISBN)

Artikel merken

Lung cancer, the most common and deadliest malignancy worldwide, is one of the biggest challenges for modern oncology. Although lung cancer presents the same incidence as breast or colorectal cancer, it causes as much deaths as breast and colorectal cancers together. Lung cancer demands our abilities as researchers, physicians, and care-givers in a multidisciplinary approach. Genetic, biology, pharmacy, pneumology, internal medicine, radiology, pathology, thoracic surgery, radiation, medical oncology and palliative care departments are essential members of the thoracic tumor boards. Fighting Lung Cancer through Conventional Therapies is the second volume of a saga entirely devoted to the treatment of lung cancer. In the age of targeted oncology, more than 90% of lung cancer patients are managed with conventional surgery, radiation, and chemotherapy only. Furthermore, 100% of them will need conventional treatments during the course of the disease. This volume updates indications, techniques, and applications of surgery, radiotherapy and chemotherapy in the treatment of lung cancer by an international team of experts. Included within these pages are: epidemiology and pathology; baseline and mediastinal staging; minimally invasive surgery, video-assisted thoracic surgery, and standard surgery in early-stage non-small cell lung cancer; radiation therapy for early non-small cell lung cancer; the management of locally advanced non-small cell cancer; applications of surgery to metastatic lung cancer; the new role of radiotherapy in metastatic non-small cell lung cancer; conventional chemotherapy as well as experimental treatments and combos with targeted therapies; the treatment of early and advanced small cell lung cancer; the role of palliative supportive care; and the integration of all those disciplines in multidisciplinary tumor boards are exhaustively reviewed.

Dr Marquez-Medina obtained his Practitioner Accreditation for the Public Health Systems of the European Community States and Medical and Surgical Degree at the Spanish University of Cordoba in 1994. From 1995 to 1998, he was trained as a translational researcher in the Reina Sofia University Hospital of Cordoba and obtained his Doctor of Philosophy Degree in 1998. In 1995, he won a position as a Medical Oncology Resident and was trained in the Integral Oncology Department of the University Hospital San Cecilio of Granada from 1998 to 2002, alternating with stages in Pediatric Oncology, Hematology and Bone Marrow Transplant Divisions in the Italian Istituto Nazionale per lo Studio e la Cura dei Tumori of Milano. Currently, he is the Staff Oncologist in charge of patients with thoracic malignancies in the Arnau de Vilanova University Hospital of Lleida (Spain), in whom he has focused on his medical practice and research activities. He did different fellowships in the thoracic cancer units from the Langone Cancer Center of New York and the Royal Marsden Hospital of London, was part of the first promotion of the European Thoracic Oncology Master Class, and completed his formation with a University Master in Health Management and work risk prevention by the Health and Social Resources School of Canarias (Spain), and an University Expert in Health Management by the Cadiz University (Spain). He was a member of the Grupo Espanol de Investigacion en Cancer de Mama (GEICAM).

For Complete Table of Contents, please visit our website at: https://www.novapublishers.com/catalog/product_info.php?products_id=55470

Verlagsort	New York
Sprache	englisch
Maße	180 x 260 mm
Gewicht	862 g
Themenwelt	Medizinische Fachgebiete ► Innere Medizin ► Pneumologie
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
ISBN-10	1-63483-275-2 / 1634832752
ISBN-13	978-1-63483-275-5 / 9781634832755
Zustand	Neuware